Agencies | Governor
Virginia Regulatory Town Hall
Agency
Virginia Department of Health
Guidance Document Information
Title Guidelines for the Use of Isoniazid/Rifapentine for Treatment of Latent TB Infection in Health Department Settings
Document ID EPI-411
Summary Provides guidance on the use of the isoniazid/rifapentine regimen for the treatment of latent tuberculosis infection. (Last review 12/2015)
Latest Revision 10/1/2012
pdf View document text     Posted On 12/30/2015                 Document on Town Hall
Explanation or Citations Based on guidance from Centers for Disease Control and Prevention. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. MMWR 2011;60:1650-1653. http://www.cdc.gov/mmwr/pdf/wk/mmy6048.pdf

This document applies to the following chapters
[12 VAC 5-90] Regulations for Disease Reporting and Control


Back to showing guidance documents for this board

Back to showing guidance documents for this agency